Zhang C, Wu Z, Li JW, Zhao H, Wang GQ (May 2020). "Cytokine release syndrome in significant COVID-19: interleukin-6 receptor antagonist tocilizumab may possibly be the crucial to cut down mortality". Depending on the style of tumor, paraneoplastic phenomena - signs or symptoms not thanks to the community presence of cancer - might to begin with attract focus to the ailment.